Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice

Antoine Babuty , Javier Muñoz-Garcia , Olivier D. Christophe , Laurie Fradet , Manon Taupin , Denis Cochonneau , Emilie Ollivier , Frank Driessler , Claudia Lange , Oleksandr Boychenko , Marie-Françoise Heymann , Dominique Heymann

Bone Research ›› 2026, Vol. 14 ›› Issue (1) : 30

PDF
Bone Research ›› 2026, Vol. 14 ›› Issue (1) :30 DOI: 10.1038/s41413-025-00485-2
Article
research-article
Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice
Author information +
History +
PDF

Abstract

In addition to its role in hemostasis, Factor VIII (FVIII) has recently been shown to potentially impact angiogenesis, inflammation, osteopenia, and sarcopenia. This was explored here by studying the musculoskeletal development of FVIII knockout (FVIII-/-) male mice. These animals developed an osteoporotic phenotype with significant bone microarchitectural alteration, reduced vascularization, and a lower osteoblastic population. Proteomic analyses revealed differentiating bone metabolism-related proteins between FVIII-/- and wildtype mice. Weekly infusions of recombinant FVIII protein reversed this phenotype. Surprisingly, younger FVIII-/- mice had heavier muscles with larger fibers, shifted from type IIx to type IIb, not reversed by FVIII treatment. Significant proteomic and metabolomic differences between wildtype and FVIII-/- muscles were observed, some of which were reduced by FVIII treatment. This study provides the first comprehensive full-phenotypic characterization of bones and muscles in FVIII-/- mice and demonstrates the benefits of FVIII supplementation to normalize their musculoskeletal phenotype.

Cite this article

Download citation ▾
Antoine Babuty, Javier Muñoz-Garcia, Olivier D. Christophe, Laurie Fradet, Manon Taupin, Denis Cochonneau, Emilie Ollivier, Frank Driessler, Claudia Lange, Oleksandr Boychenko, Marie-Françoise Heymann, Dominique Heymann. Factor VIII restores bone parameters and modulates muscle proteo-metabolome in Factor VIII knockout male mice. Bone Research, 2026, 14(1): 30 DOI:10.1038/s41413-025-00485-2

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Malik A, Rehman FU, Shah KU, Naz SS, Qaisar S. Hemostatic strategies for uncontrolled bleeding: a comprehensive update. J. Biomed. Mater. Res. B Appl. Biomater.. 2021, 109: 1465-1477.

[2]

Kim S, Carrillo M, Kulkarni V, Jagadeeswaran P. Evolution of primary hemostasis in early vertebrates. PLoS One. 2009, 4: e8403.

[3]

Lenting PJ, Christophe OD, Guéguen P. The disappearing act of factor VIII. Haemophilia. 2010, 166-15.

[4]

Valentino LA, Khair K. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations. Expert Rev. Hematol.. 2020, 13: 731-743.

[5]

Peyvandi F, Garagiola I, Young G. The past and future of haemophilia: diagnosis, treatments, and its complications. Lancet. 2016, 388: 187-97.

[6]

Soucek Oet al. . Boys with haemophilia have low trabecular bone mineral density and sarcopenia, but normal bone strength at the radius. Haemophilia. 2012, 18: 222-8.

[7]

Cadé Met al. . FVIII at the crossroad of coagulation, bone and immune biology: emerging evidence of biological activities beyond hemostasis. Drug Discov. Today. 2022, 27: 102-116.

[8]

Rodriguez-Merchan EC, Valentino LA. Increased bone resorption in hemophilia. Blood Rev.. 2019, 33: 6-10.

[9]

Goldscheitter G, Recht M, Sochacki P, Manco-Johnson M, Taylor JA. Biomarkers of bone disease in persons with haemophilia. Haemophilia. 2021, 27: 149-155.

[10]

Fouasson-Chailloux Aet al. . Isokinetic knee strength deficit in patients with moderate haemophilia. Haemophilia. 2021, 27: 634-640.

[11]

Uzuner B, Ketenci S, Durmus D, Atay HM. The frequency of sarcopenia in haemophilia patients: effects on musculoskeletal health and functional performance. Haemophilia. 2024, 30: 505-512.

[12]

Kaczmarek, R., Miesbach, W., Ozelo, M. C., Chowdary P. Current and emerging gene therapies for haemophilia A and B. Haemophilia. 2024 12–20.

[13]

Lau AGet al. . Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement. Haemophilia. 2014, 20: 716-22. Sep

[14]

Taves Set al. . Hemophilia A and B mice, but not VWF-/- mice, display bone defects in congenital development and remodeling after injury. Sci. Rep.. 2019, 9. 14428

[15]

Liel MSet al. . Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency. Br. J. Haematol.. 2012, 158: 140-3.

[16]

Larson E, Taylor JA. Factor VIII plays a direct role in osteoblast development. Blood. 2017, 130: 3661

[17]

Mackie EJet al. . Protease-activated receptors in the musculoskeletal system. Int. J. Biochem Cell Biol.. 2008, 401169-84.

[18]

Aronovich Aet al. . A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood. 2013, 122: 2562-71. 10

[19]

Tudpor Ket al. . Thrombin receptor deficiency leads to a high bone mass phenotype by decreasing the RANKL/OPG ratio. Bone. 2015, 72: 14-22.

[20]

Anagnostis Pet al. . The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B. Haemophilia. 2014, 20: 268-75.

[21]

Dzamukova Met al. . Mechanical forces couple bone matrix mineralization with inhibition of angiogenesis to limit adolescent bone growth. Nat. Commun.. 2022, 13. 3059

[22]

Stucker S, Chen J, Watt FE, Kusumbe AP. Bone angiogenesis and vascular niche remodeling in stress, aging, and diseases. Front. Cell Dev. Biol.. 2020, 8. 602269

[23]

Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014, 507: 323-328.

[24]

Dempster DWet al. . Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone. 2013, 28: 2-17

[25]

Wang F, Rummukainen P, Heino TJ, Kiviranta R. Osteoblastic Wnt1 regulates periosteal bone formation in adult mice. Bone. 2021, 143. 115754

[26]

Ademovic Zet al. . The method of surface PEGylation influences leukocyte adhesion and activation. J. Mater. Sci. Mater. Med.. 2006, 17: 203-11.

[27]

Guardiola, O. et al. Induction of acute skeletal muscle regeneration by cardiotoxin injection. J. Vis. Exp. 2017:54515.

[28]

Lee A, Boyd SK, Kline G, Poon MC. Premature changes in trabecular and cortical microarchitecture result in decreased bone strength in hemophilia. Blood. 2015, 125: 2160-2163.

[29]

Cooke EJet al. . Mechanisms of vascular permeability and remodeling associated with hemarthrosis in Factor VIII-deficient mice. J. Thromb. Haemost.. 2019, 17: 1815-1826.

[30]

Jardimet al. . Immune status of patients with haemophilia A beforeexposure to factor VIII: first results from the HEMFIL study. Br. J. Haematol.. 2017, 178: 971-978.

[31]

Chevalley T, Rizzoli R. Acquisition of peak bone mass. Best. Pr. Res Clin. Endocrinol. Metab.. 2022, 36. 101616

[32]

Cadé Met al. . FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior. Cell Mol. Life Sci.. 2022, 79: 145. 21

[33]

Olgasi Cet al. . Factor VIII promotes angiogenesis and vessel stability regulating extracellular matrix proteins. Haematologica. 2024, 1093391-3397. 1

[34]

Vicario N, Parenti R. Connexins signatures of the neurovascular unit and their physio-pathological functions. Int. J. Mol. Sci.. 2022, 23: 9510.

[35]

Alarcon-Martinez Let al. . Pericyte dysfunction and loss of interpericyte tunneling nanotubes promote neurovascular deficits in glaucoma. Proc. Natl. Acad. Sci. USA. 2022, 119. e2110329119

[36]

Uemura MT, Maki T, Ihara M, Lee VMY, Trojanowski JQ. Brain microvascular pericytes in vascular cognitive impairment and dementia. Front. Aging Neurosci.. 2020, 1412-80

[37]

Shrouder JJet al. . Continued dysfunction of capillary pericytes promotes no-reflow after experimental stroke in vivo. Brain. 2024, 147: 1057-1074.

[38]

Zhu Jet al. . Pericyte signaling via soluble guanylate cyclase shapes the vascular niche and microenvironment of tumors. EMBO J.. 2024, 43: 1519-1544.

[39]

Weitzmann MNet al. . Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice. Blood Adv.. 2019, 3: 288-300.

[40]

Baud’huin Met al. . Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. J. Biol. Chem.. 2009, 284: 31704-13.

[41]

Battafarano Get al. . Effects of coagulation factors on bone cells and consequences of their absence in haemophilia a patients. Sci. Rep.. 2024, 14. 25001

[42]

El-Masri BMet al. . Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect. Bone Res.. 2024, 12: 62.

[43]

Tanaka Ket al. . Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone. 2012, 51158-67.

[44]

Zhu S, Chen W, Masson A, Li YP. Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis. Cell Discov.. 2024, 10: 71. 2

[45]

Granot-Attas S, Elson A. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Eur. J. Cell Biol.. 2008, 87479-90.

[46]

Moester MJ, Papapoulos SE, Löwik CW, van Bezooijen RL. Sclerostin: current knowledge and future perspectives. Calcif. Tissue Int. 2010, 87: 99-107.

[47]

El-Mikkawy DME, Elbadawy MA, Abd El-Ghany SM, Samaha D. Serum Sclerostin level and bone mineral density in pediatric hemophilic Arthropathy. Indian J. Pediatr.. 2019, 86: 515-519.

[48]

Giordano Pet al. . High serum sclerostin levels in children with haemophilia A. Br. J. Haematol.. 2016, 172: 293-5.

[49]

Kurmi K, Haigis MC. Nitrogen metabolism in cancer and immunity. Trends Cell Biol.. 2020, 30: 408-424.

[50]

Solmonson Aet al. . Compartmentalized metabolism supports midgestation mammalian development. Nature. 2022, 604: 349-353.

[51]

Chen TH, Koh KY, Lin KM, Chou CK. Mitochondrial dysfunction as an underlying cause of skeletal muscle disorders. Int. J. Mol. Sci.. 2022, 23: 12926. 26

[52]

Figueiredo VCet al. . Ribosome biogenesis and degradation regulate translational capacity during muscle disuse and reloading. J. Cachexia Sarcopenia Muscle. 2021, 12130-143.

[53]

Fitzgerald LF, Bartlett MF, Kent JA. Muscle fatigue, bioenergetic responses and metabolic economy during load- and velocity-based maximal dynamic contractions in young and older adults. Physiol. Rep.. 2023, 11. e15876

[54]

Berchtold MW, Brinkmeier H, Müntener M. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev.. 2000, 80: 1215-65.

[55]

Schiaffino S, Reggiani C. Fiber types in mammalian skeletal muscles. Physiol. Rev.. 2011, 91: 1447-531.

[56]

Booth FW, Thomason DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol. Rev.. 1991, 71: 541-85.

[57]

Zhang MY, Zhang WJ, Medler S. The continuum of hybrid IIX/IIB fibers in normal mouse muscles: MHC isoform proportions and spatial distribution within single fibers. Am. J. Physiol. Regul. Integr. Comp. Physiol.. 2010, 299: R1582-91.

[58]

Eggers Bet al. . Advanced fiber type-specific protein profiles derived from adult murine skeletal muscle. Proteomes. 2021, 9: 28. 8

[59]

Shafy Aet al. . Comparison of the effects of adenosine, inosine, and their combination as an adjunct to reperfusion in the treatment of acute myocardial infarction. ISRN Cardiol.. 2012, 2012. 326809

[60]

Phang JM, Liu W, Zabirnyk O. Proline metabolism and microenvironmental stress. Annu. Rev. Nutr.. 2010, 30441-63.

[61]

Wang Tet al. . Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction. Nat. Metab.. 2020, 2: 635-647.

[62]

Cervelli Met al. . Skeletal muscle pathophysiology: the emerging role of spermine oxidase and spermidine. Med. Sci.. 2018, 6: 14

[63]

Kohen R, Yamamoto Y, Cundy KC, Ames BN. Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain. Proc. Natl. Acad. Sci. USA. 1988, 853175-9.

[64]

Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling. Annu. Rev. Biochem. 2006, 75: 19-37.

[65]

Lillioja Set al. . Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest.. 1987, 80: 415-24.

[66]

Gray SD, McDonagh PF, Gore RW. Comparison of functional and total capillary densities in fast and slow muscles of the chicken. Pflug. Arch.. 1983, 397: 209-13.

[67]

Egginton S, Turek Z, Hoofd LJ. Differing patterns of capillary distribution in fish and mammalian skeletal muscle. Respir. Physiol.. 1988, 74: 383-96.

[68]

Messa GAMet al. . Morphological alterations of mouse skeletal muscles during early ageing are muscle specific. Exp. Gerontol.. 2019, 125. 1106841

[69]

Shahani Tet al. . Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII. J. Thromb. Haemost.. 2014, 12: 36-42.

[70]

Sun Het al. . Adult males with haemophilia have a different macrovascular and microvascular endothelial function profile compared with healthy controls. Haemophilia. 2017, 23: 777-783.

[71]

Cooke EJet al. . Vascular permeability and remodelling coincide with inflammatory and reparative processes after joint bleeding in Factor VIII-deficient mice. Thromb. Haemost.. 2018, 118: 1036-1047.

[72]

Knowles LMet al. . Macrophage polarization is deregulated in Haemophilia. Thromb. Haemost.. 2019, 119: 234-245.

[73]

Nieuwenhuizen Let al. . Hemarthrosis in hemophilic mice results in alterations in M1-M2 monocyte/macrophage polarization. Thromb. Res.. 2014, 133: 390-395.

[74]

Montagutelli X, Abitbol M. Applications of congenic strains in the mouse. Med. Sci.. 2004, 20: 887-93

[75]

Gobin Bet al. . BYL719, a new α-specific PI3K inhibitor: single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma. Int. J. Cancer. 2015, 136: 784-96.

[76]

Bian Yet al. . Robust, reproducible and quantitative analysis of thousands of proteomes by micro-flow LC-MS/MS. Nat. Commun.. 2020, 11. 157

[77]

Bian Yet al. . Robust microflow LC-MS/MS for Proteome analysis: 38 000 runs and counting. Anal. Chem.. 2021, 93: 3686-3690.

[78]

Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom.. 1994, 5: 976-89.

[79]

Zolg DPet al. . INFERYS rescoring: boosting peptide identifications and scoring confidence of database search results. Rapid Commun. Mass Spectrom.. 2021, 20e9128

[80]

Käll L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat. Methods. 2007, 4: 923-5.

[81]

Dorfer Vet al. . MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectra. J. Proteome Res.. 2014, 13: 3679-84.

[82]

von Mering Cet al. . STRING: a database of predicted functional associations between proteins. Nucleic Acids Res.. 2003, 31: 258-61.

[83]

Szklarczyk Det al. . The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res.. 2023, 51: D638-D646.

Funding

Shire (Shire plc)

Bayer

RIGHTS & PERMISSIONS

The Author(s)

PDF

0

Accesses

0

Citation

Detail

Sections
Recommended

/